Namuscla
Non-Dystrophic Myotonia
Grete Andersen, MDN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Non-Dystrophic Myotonia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LAMOTRIGINE Grete Andersen, MD | N/A | D |
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →